These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 22727107)
1. Treatment of mucous membrane pemphigoid with the combination of mycophenolate mofetil, dapsone, and prednisolone: a case series. Staines K; Hampton PJ Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Jul; 114(1):e49-56. PubMed ID: 22727107 [TBL] [Abstract][Full Text] [Related]
2. [Anti-p200 pemphigoid: Remission under mycophenolate mofetil (Cellcept®)]. Raffin D; Delaplace M; Roussel A; Estève E Ann Dermatol Venereol; 2013 Dec; 140(12):784-7. PubMed ID: 24315224 [TBL] [Abstract][Full Text] [Related]
4. Treatment of cicatricial pemphigoid with mycophenolate mofetil as a steroid-sparing agent. Megahed M; Schmiedeberg S; Becker J; Ruzicka T J Am Acad Dermatol; 2001 Aug; 45(2):256-9. PubMed ID: 11464188 [TBL] [Abstract][Full Text] [Related]
5. Treatment of mucous membrane pemphigoid with mycophenolate mofetil. Nottage JM; Hammersmith KM; Murchison AP; Felipe AF; Penne R; Raber I Cornea; 2013 Jun; 32(6):810-5. PubMed ID: 23132447 [TBL] [Abstract][Full Text] [Related]
9. Update on ocular cicatricial pemphigoid and emerging treatments. Queisi MM; Zein M; Lamba N; Meese H; Foster CS Surv Ophthalmol; 2016; 61(3):314-7. PubMed ID: 26708362 [TBL] [Abstract][Full Text] [Related]
10. Mucous membrane pemphigoid with antibodies against β3 subunit of laminin-332: first report from India. Kanwar AJ; Vinay K; Koga H; Hashimoto T Indian J Dermatol Venereol Leprol; 2012; 78(4):475-9. PubMed ID: 22772619 [TBL] [Abstract][Full Text] [Related]
11. A case of antilaminin 332 mucous membrane pemphigoid showing a blister on the bulbar conjunctiva and a unique epitope on the alpha3 subunit. Hashimoto T; Dainichi T; Ohyama B; Hamada T; Ishii N; Sato N; Tanigawa O; Nakayama J; Amano S; Nishiyama T; Karashima T; Nakama T; Yasumoto S Br J Dermatol; 2010 Apr; 162(4):898-9. PubMed ID: 20199543 [No Abstract] [Full Text] [Related]